- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Healthy, no Evidence of Disease in Japan
Total 324 results
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1941 | Pharmacokinetics of MitiglinideJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of QuetiapineJapan
-
Astellas Pharma IncCompletedA Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941Healthy | Pharmacokinetics of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of AtorvastatinJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of EnalaprilJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP7991Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP0456Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP0456Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompletedA Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male SubjectsHealthy | Pharmacokinetics of ASP2408Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP7991Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ValsartanJapan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of ASP015KJapan
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of ASP1941Japan
-
Astellas Pharma IncCompletedPost-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of TolterodineHealthy | Pharmacokinetics of Mirabegron and TolterodineJapan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration Change of QuetiapineJapan
-
Astellas Pharma IncCompletedHealthy Subjects | Plasma Concentration of MirabegronJapan
-
Astellas Pharma IncCompletedHealthy Elderly Subject | Pharmacokinetic of YM150Japan
-
Astellas Pharma IncToray Industries, IncCompletedHealthy Adult Male | Pharmacokinetics of TRK-100-STPJapan
-
UMN Pharma Inc.CompletedHealthy | Immunogenicity of ASP7374Japan
-
National Center for Geriatrics and Gerontology,...GE HealthcareCompleted
-
MOA Health Science FoundationCompletedMental Disorders | Healthy | Physical DisordersJapan
-
Astellas Pharma IncCompletedPharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male SubjectsJapan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM178Japan
-
Jewish General HospitalCompletedQuality of Life | Health, Subjective | Social InteractionCanada, Japan
-
Anwar Ali Ahmad AlameerCompletedEffect of Health Education Regarding Screening Tools of Breast CancerSaudi Arabia
-
TakedaCompletedHealthy Participants | NarcolepsyJapan
-
Janssen Pharmaceutical K.K.Completed
-
Toray Industries, IncCompleted
-
Otsuka Pharmaceutical Co., Ltd.EPS CorporationCompletedHealthy | Gastric Acid-related DiseasesJapan
-
TakedaCompletedHealthy Participants and Patients With NarcolepsyJapan
-
TakedaCompleted
-
Janssen Pharmaceutical K.K.Completed
-
Taisho Pharmaceutical Co., Ltd.Nagoya UniversityCompleted
-
TakedaCompletedJapanese Healthy Adult Male ParticipantsJapan
-
UCB Biopharma SRLCompletedHealthy Study ParticipantsJapan
-
AstraZenecaCompleted
-
UMN Pharma Inc.Completed
-
Mochida Pharmaceutical Company, Ltd.Fuji Yakuhin Co., Ltd.CompletedHepatic Insufficiency | HealthyJapan
-
AstraZenecaCompletedHealthy VolunteerJapan
-
AstraZenecaCompleted